Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock.

作者: Michael Oppert , Albrecht Reinicke , Klaus-Jürgen Gräf , Detlef Barckow , Ulrich Frei

DOI: 10.1007/S001340000685

关键词:

摘要: Objectives: To compare cortisol levels during "low-dose" hydrocortisone therapy to basal and ACTH-stimulated endogenous assess whether clinical course the need for catecholamines depend on and/or pretreatment adrenocortical responsiveness. Design setting: Prospective observational study in a medical ICU of university hospital. Patients: Twenty consecutive patients with septic shock cardiac index 3.5 l/min or higher, started (100 mg bolus, 10 mg/h 7 days subsequent tapering) within 72 h onset shock. Measurements results: Basal total free plasma ranged from 203 2169 17 372 nmol/l. In 11 production was considered "inadequate" because there neither response ACTH at least 200 nmol/l nor baseline level 1000 nmol/l. Following initiation increased 4.2- 8.5-fold median 3587 (interquartile range 2679–5220) 1210 750–1846) nmol/l day 1, thereafter declined 1310 nmol/l 345 nmol/l 7. Patients steroid could be weaned vasopressor significantly faster, although their concentrations treatment period did not differ. Conclusions: (a) During proposed regimens therapy, initially achieved considerably exceed stimulated levels. (b) Cortisol decline subsequently, despite continuous application constant dose. (c) "Inadequate" appears sensitize hemodynamic effects "therapeutic rise"

参考文章(16)
Josef Briegel, Helmuth Forst, Hildegard Hellinger, Mathias Haller, Contribution of cortisol deficiency to septic shock The Lancet. ,vol. 338, pp. 507- 508 ,(1991) , 10.1016/0140-6736(91)90575-A
Jean-Luc Coolens, Hugo Van Baelen, Walter Heyns, Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin Journal of Steroid Biochemistry. ,vol. 26, pp. 197- 202 ,(1987) , 10.1016/0022-4731(87)90071-9
Roger C. Bone, Charles J. Fisher, Terry P. Clemmer, Gus J. Slotman, Craig A. Metz, Robert A. Balk, , A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. The New England Journal of Medicine. ,vol. 317, pp. 653- 658 ,(1987) , 10.1056/NEJM198709103171101
J. Briegel, W. Kellermann, H. Forst, M. Haller, M. Bittl, G.E. Hoffmann, M. B�chler, W. Uhl, K. Peter, , Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome Journal of Molecular Medicine. ,vol. 72, pp. 782- 787 ,(1994) , 10.1007/BF00180547
Thomas H. Jurney, James L. Cockrell, Thomas H. Jurney, Jill S. Lindberg, James M. Lamiell, Charles E. Wade, Spectrum of Serum Cortisol Response to ACTH in ICU Patients: Correlation with Degree of Illness and Mortality Chest. ,vol. 92, pp. 292- 295 ,(1987) , 10.1378/CHEST.92.2.292
DANIEL PERROT, AGNÉS BONNETON, HENRI DECHAUD, JEAN MOTIN, MICHEL PUGEAT, Hypercortisolism in septic shock is not suppressible by dexamethasone infusion Critical Care Medicine. ,vol. 21, pp. 396- 401 ,(1993) , 10.1097/00003246-199303000-00018
ROLAND M. H. SCHEIN, CHARLES L. SPRUNG, EILEEN MARCIAL, LENA NAPOLITANO, BART CHERNOW, Plasma cortisol levels in patients with septic shock Critical Care Medicine. ,vol. 18, pp. 259- 263 ,(1990) , 10.1097/00003246-199003000-00002
Lisa Cronin, Deborah J. Cook, Jean Carlet, Daren K. Heyland, Derek B Math King, Mary Ann D. Lansang, Jr Fisher, Corticosteroid treatment for sepsis Critical Care Medicine. ,vol. 23, pp. 1430- 1439 ,(1995) , 10.1097/00003246-199508000-00019
G. Bouachour, P. Tirot, J. P. Gouello, E. Mathieu, J. F. Vincent, Ph. Alquier, Adrenocortical function during septic shock. Intensive Care Medicine. ,vol. 21, pp. 57- 62 ,(1995) , 10.1007/BF02425155